LOS ANGELES, April 6, 2005 (PRIMEZONE) -- SmallcapInsights.com, http://www.SmallcapInsights.com, the online source for exclusive commentary, research, interviews and other key investor information, has announced the availability of an audio interview with Patricia McPeak, CEO of NutraCea(r) (OTCBB:NTRZ), a leader in the science of whole food nutrition and proprietary healthcare products based on stabilized rice bran. In the interview, Ms. McPeak discusses the business and strategic implications of the Company's recently announced definitive agreement to merge with the RiceX Company.
In the interview, Ms. McPeak discussed NutraCea's leadership position in a number of multi-billion-dollar global markets for the nutritionally dense products that NutraCea can produce from stabilized rice bran. The rice bran, normally lost in processing rice for consumption, is one of the must nutritionally dense foods available, she said. Although rice is the world's most widely-consumed cereal grains, most rice bran is discarded as waste.
"NutraCea entered this merger with exclusive intellectual property technology to create a range of proprietary stabilized rice bran product formulations, deliver systems and advanced whole food nutritional products," said Ms. McPeak. "RiceX brought exclusive control of the world's major supply of the highest quality rice bran as well as a proprietary rice bran stabilization process that allows for the creation of nutritionally dense foods for the global food manufacturing and equine feed industries. The combination of our two companies will enable us to ensure our leadership role in the creation of next-generation nutritional products for human and animal consumption, as well as to capture a large share of the $64 billion medical foods and nutraceutical markets, and the $34 billion pet care market."
The streaming audio interview can be accessed at http://www.SmallcapInsights.com. Registration to listen to the interview is free.
About NutraCea(r)
NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. The Company has developed intellectual property to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a waste by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health-promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products, and all-natural "cosmeceutical" beauty aids. For more information, visit http://www.NutraCea.com. For more information, visit http://www.NutraCea.com. For investor-specific information, including daily and historical Company stock quote data and recent news releases, please visit http://www.trilogy-capital.com/tcp/nutracea. To read or download the Company's Investor Fact Sheet visit http://www.trilogy-capital.com/tcp/nutracea/factsheet.html.
About Smallcap Insights
Smallcap Insights provides exclusive commentary, research, interviews and other information about the smallcap investment marketplace. Smallcap Insights strives to provide investors with information and research-based data regarding important individual companies and overall marketplace trends. Resources available on SmallcapInsights.com include audio interviews with corporate leaders and respected commentators, as well as technical white papers and other forms of market and investment analysis. It is located at http://www.SmallcapInsights.com.
Forward Looking Statements
This press release includes forward-looking statements. These statements may be identified by the use of forward-looking terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "should," or "will," or the negative thereof or other variations thereon or comparable terminology. In particular, forward-looking statements include, without limitation, statements related to the expected synergies of the combined companies, the anticipated cost savings resulting from the business combination, the ability of the combined company to achieve significantly greater size and scale, the ability of the combined company to achieve sustainable profitability and to continue to develop competitive new products, the timing of the completion of the proposed business combination, and future financial and operating results. NutraCea and RiceX have based these forward-looking statements on the current expectations, assumptions, estimates and projections. While NutraCea and RiceX believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These risks include: the risk that the combined company may not achieve the benefits expected from the transaction, which may have a material adverse effect on the combined company's business and could result in loss of key personnel, the risk that the transaction may be completed even though material adverse changes may result from the announcement of the transaction, industry-wide changes and other causes, the risk that the combined company may not be able to develop new competitive products and the risk that the transaction may not be completed or that the closing of the transaction may be delayed due to failure to obtain regulatory or other approvals or the occurrence of a material adverse change in one or both of the parties. These and other important factors, including those discussed in NutraCea's and RiceX's annual reports on Form 10-KSB for the year ended December 31, 2004, may cause the actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. We do not undertake any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments.
Compensation and Other Disclosures
Smallcap Insights is a wholly-owned subsidiary of Trilogy Capital Partners, Inc. Trilogy Capital Partners provides investor relations services to public companies. The companies presented by Smallcap Insights are usually clients of Trilogy Capital Partners and compensate Trilogy Capital Partners for these services, including cash compensation and equity securities. In addition, Trilogy Capital Partners and its affiliates may own securities of the presenting companies, and may from time to time purchase and sell securities of these companies in the open market or in private transactions. NutraCea pays Trilogy $10,000 per month through February 2006 and thereafter for so long as Trilogy is retained to provide investor relations services. Trilogy has warrants from this company to purchase 2.1 million shares of common stock, as follows: 700,000 at an exercise price of $0.45, 700,000 at $0.65 and 700,000 at $0.85.